Uni-Bio Science Group Limited (0690.HK)
0690.HK Stock Price Chart
Explore Uni-Bio Science Group Limited interactive price chart. Choose custom timeframes to analyze 0690.HK price movements and trends.
0690.HK Company Profile
Discover essential business fundamentals and corporate details for Uni-Bio Science Group Limited (0690.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Nov 2001
Employees
487.00
Website
https://www.uni-bioscience.comCEO
Zhi Gang Zhao CPA, MSc
Description
Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Bokangtai, a mitiglinide tablet for the treatment of Type 2 diabetes, as well as Boshutai, an oral anti-diabetic drug targeting patients with pre-diabetes condition. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agonist, a non-insulin treatment candidate for the treatment of Type 2 diabetes. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong.
0690.HK Financial Timeline
Browse a chronological timeline of Uni-Bio Science Group Limited corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 28 May 2025
A dividend of $0.00 per share was announced, adjusted to $0.00. The dividend was paid on 13 Jun 2025.
Earnings released on 27 Mar 2025
EPS came in at $0.00 , while revenue for the quarter reached $279.37M .
Earnings released on 28 Aug 2024
EPS came in at $0.01 , while revenue for the quarter reached $273.62M .
Earnings released on 28 Mar 2024
EPS came in at $0.00 , while revenue for the quarter reached $234.79M .
Earnings released on 28 Aug 2023
EPS came in at $0.01 , while revenue for the quarter reached $249.93M .
Earnings released on 28 Mar 2023
EPS came in at $0.00 , while revenue for the quarter reached $244.74M .
Earnings released on 29 Aug 2022
EPS came in at $0.00 , while revenue for the quarter reached $195.58M .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 , while revenue for the quarter reached $196.42M .
Earnings released on 30 Jun 2021
EPS came in at $0.00 , while revenue for the quarter reached $156.98M .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $141.34M .
0690.HK Stock Performance
Access detailed 0690.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.